The metabolic syndrome and risk of prostate cancer in Italy - PubMed (original) (raw)
The metabolic syndrome and risk of prostate cancer in Italy
Claudio Pelucchi et al. Ann Epidemiol. 2011 Nov.
Abstract
Purpose: To provide information on the role of the metabolic syndrome on prostate cancer risk.
Methods: We examined data from a multicentric Italian case-control study. Cases were 1294 patients with incident, histologically confirmed prostate cancer. Controls were 1451 men hospitalized with acute, non-neoplastic conditions. All subjects were younger than 75 years. The metabolic syndrome was defined according to selected indicators of abdominal obesity, hypercholesterolemia, hypertension, and diabetes. We computed multivariate odds ratios (OR) and 95% confidence intervals (CI) using unconditional logistic regression.
Results: Considering separate components of the metabolic syndrome, the ORs were 0.98 (95% CI, 0.72-1.34) for diabetes, 1.14 (95% CI, 0.96-1.36) for hypertension, 1.54 (95% CI, 1.26-1.89) for hypercholesterolemia, and 1.02 (95% CI, 0.86-1.21) for abdominal obesity. The OR of prostate cancer was 1.66 (95% CI, 1.22-2.28) in men with metabolic syndrome compared with those without. We found ORs of 1.02 (95% CI, 0.83-1.26) for men with one component of the metabolic syndrome, 1.12 (95% CI, 0.89-1.42) for two, 1.65 (95% CI, 1.15-2.36) for three, and 3.99 (95% CI, 1.03-15.4) for four compared with no components.
Conclusions: The metabolic syndrome was associated with the risk of prostate cancer in this population.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
- Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis.
Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Parretta E, Lenzi A, Giugliano D. Esposito K, et al. J Endocrinol Invest. 2013 Feb;36(2):132-9. doi: 10.1007/BF03346748. J Endocrinol Invest. 2013. PMID: 23481613 Review. - Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study.
Montella M, Di Maso M, Crispo A, Grimaldi M, Bosetti C, Turati F, Giudice A, Libra M, Serraino D, La Vecchia C, Tambaro R, Cavalcanti E, Ciliberto G, Polesel J. Montella M, et al. BMC Cancer. 2015 Oct 16;15:720. doi: 10.1186/s12885-015-1769-9. BMC Cancer. 2015. PMID: 26475132 Free PMC article. - Metabolic disorders and the risk of nasopharyngeal carcinoma: a case-control study in Italy.
Zucchetto A, Taborelli M, Bosetti C, Montella M, La Vecchia C, Franchin G, Libra M, Serraino D, Polesel J. Zucchetto A, et al. Eur J Cancer Prev. 2018 Mar;27(2):180-183. doi: 10.1097/CEJ.0000000000000286. Eur J Cancer Prev. 2018. PMID: 27479542 - Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.
Blanc-Lapierre A, Spence A, Karakiewicz PI, Aprikian A, Saad F, Parent MÉ. Blanc-Lapierre A, et al. BMC Public Health. 2015 Sep 18;15:913. doi: 10.1186/s12889-015-2260-x. BMC Public Health. 2015. PMID: 26385727 Free PMC article. - Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis.
Todowede OO, Mianda SZ, Sartorius B. Todowede OO, et al. Syst Rev. 2019 Jan 3;8(1):4. doi: 10.1186/s13643-018-0927-y. Syst Rev. 2019. PMID: 30606249 Free PMC article.
Cited by
- Meta-analysis of metabolic syndrome and prostate cancer.
Gacci M, Russo GI, De Nunzio C, Sebastianelli A, Salvi M, Vignozzi L, Tubaro A, Morgia G, Serni S. Gacci M, et al. Prostate Cancer Prostatic Dis. 2017 Jun;20(2):146-155. doi: 10.1038/pcan.2017.1. Epub 2017 Feb 21. Prostate Cancer Prostatic Dis. 2017. PMID: 28220805 Review. - Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis.
Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Parretta E, Lenzi A, Giugliano D. Esposito K, et al. J Endocrinol Invest. 2013 Feb;36(2):132-9. doi: 10.1007/BF03346748. J Endocrinol Invest. 2013. PMID: 23481613 Review. - High salt intake combined with hypertension elevated the risk of primary liver cancer: a prospective cohort study.
Liu T, Zhang Q, Xiao X, Wang Y, Ma X, Song M, Zhang Q, Cao L, Shi H. Liu T, et al. Front Oncol. 2022 Aug 3;12:916583. doi: 10.3389/fonc.2022.916583. eCollection 2022. Front Oncol. 2022. PMID: 35992793 Free PMC article. - Obesity, Type 2 Diabetes, and Cancer Risk.
Scully T, Ettela A, LeRoith D, Gallagher EJ. Scully T, et al. Front Oncol. 2021 Feb 2;10:615375. doi: 10.3389/fonc.2020.615375. eCollection 2020. Front Oncol. 2021. PMID: 33604295 Free PMC article. Review. - Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study.
Iyer PG, Borah BJ, Heien HC, Das A, Cooper GS, Chak A. Iyer PG, et al. Clin Gastroenterol Hepatol. 2013 Sep;11(9):1108-1114.e5. doi: 10.1016/j.cgh.2013.03.024. Epub 2013 Apr 13. Clin Gastroenterol Hepatol. 2013. PMID: 23591277 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical